Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review

Post-transplant cyclophosphamide-induced cardiotoxicity: A comprehensive review

Cyclophosphamide-induced cardiotoxicity, associated with its toxic metabolite acrolein, is a significant concern and unresolved issue, especially when cyclophosphamide is administrated in high doses. However, cardiotoxicity following low-dose cyclophosphamide has been also documented, especially in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Azin Alizadehasl, Bita Shahrami, Reza Rahbarghazi, Azam Yalameh Aliabadi, Seyedeh Fatemeh Hosseini Jebelli, Yasamin Afsari Zonooz, Hoda Hakimian, Farzaneh Fathi, Sara Forati, Aysa Rezabakhsh
Format:	Article
Language:	English
Published:	Tabriz University of Medical Sciences 2024-12-01
Series:	Journal of Cardiovascular and Thoracic Research
Subjects:	angiogenesis acrolein cardiotoxicity cyclophosphamide hematopoietic stem cell transplantation
Online Access:	https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-16-211.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hydrogen sulfide and ferroptosis inhibition underlies the dietary restriction-induced protection against cyclophosphamide cystitis
by: Zhimin Mao, et al.
Published: (2025-05-01)

Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)

The effect of quercetin application on desmin and vimentin levels in ovariectomized rats with cyclophosphamide-induced cardiotoxicity
by: Şükran YEDİEL ARAS, et al.
Published: (2025-05-01)

A Comprehensive Insight Into Primary Intimal Sarcoma of the Pulmonary Artery; From Diagnosis to Management: A Case Report and Review of the Literature
by: Azin Alizadehasl, et al.
Published: (2024-11-01)

Cardiotoxicity of Anticancer Drugs
by: I. Maiborodin, et al.
Published: (2025-02-01)

Radiomics early assessment of post chemotherapy cardiotoxicity in cancer patients using 2D echocardiography imaging an interpretable machine learning study
by: Masumeh Ahmadi, et al.
Published: (2025-08-01)

Carbamazepine Cardiotoxicity
by: J Gordon Millichap
Published: (1993-10-01)

Investigation of cardiotoxic effects of marbofloxacin
by: Devran Coşkun, et al.

Protective effects and metabolomics analysis of dihydromyricetin on cyclophosphamide-induced hepatotoxicity in mice
by: Fei Teng, et al.
Published: (2025-12-01)

Trastuzumab and cardiotoxicity
by: Petra Sertić, et al.
Published: (2024-01-01)

Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01)

Theoretical investigation of the mechanism, kinetics and subsequent degradation products of the NO3 radical initiated oxidation of acrolein
by: Yunju Zhang, et al.
Published: (2025-02-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis
by: Yen Yen Ari Indrawijaya, et al.
Published: (2023-11-01)

Rapidly progressive pleuro-parenchymal fibroelastosis secondary to cyclophosphamide chemotherapy
by: Maheema Bhaskar, et al.
Published: (2020-01-01)

Experimental Study on Cytoflavin Pharmacological Correction of Cyclophosphamide-Induced Toxic Affections of the Liver and Kidneys
by: V. A. Kashuro, et al.
Published: (2020-05-01)

Menstrual and Hormonal Changes in Breast Cancer Patients Treated By Ad- juvant, Adriamycin and Cyclophosphamide Chemotherapy
by: Jangi Shawkat Muhialdin Salai, et al.
Published: (2023-01-01)

Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
by: Ramaswamy Subramanian, et al.
Published: (2019-01-01)

Meta-analysis of calcineurin inhibitor vs.cyclophosphamide in the treatment of idiopathic membranous nephropathy
by: XIE Guang-liang, et al.
Published: (2015-01-01)

Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma
by: Yan Wang, et al.
Published: (2025-02-01)

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy
by: Tao Wang, et al.
Published: (2025-12-01)

Role of hesperidin/hesperetin against chemotherapy-induced cardiotoxicity: a systematic review of non-clinical studies
by: Sina Shaernejad, et al.
Published: (2025-05-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Alpha Tocopherol Outperforms Melatonin and Silymarin Antioxidant Defense Against Cyclophosphamide Induced Cardiorenal Toxicity
by: Maryam Saqib, et al.
Published: (2024-12-01)

Alpha Tocopherol Outperforms Melatonin and Silymarin Antioxidant Defense Against Cyclophosphamide Induced Cardiorenal Toxicity
by: Maryam Saqib, et al.
Published: (2024-12-01)

Frequency of cardiotoxicity following intramuscular administration of epinephrine in emergency department patients with anaphylaxis
by: Emily K. Pauw, et al.
Published: (2024-02-01)

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis
by: Gabriel Sauvage, et al.
Published: (2025-03-01)

c-Myc Inhibition Induces an Additive Effect with Cyclophosphamide in Acute Lymphoblastic Leukemia
by: Mohammad Sadeghi, et al.
Published: (2024-08-01)

Mechanisms of cell senescence and apoptosis in cyclophosphamide-induced premature ovarian failure in rats
by: Jiaqi Wu, et al.
Published: (2025-07-01)

Types of chromosomal abnormalities caused by chemotherapy cyclophosphamide in mice (Mus musculus L.)
by: Wasan Moayad Shaker, et al.
Published: (1970-01-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Multidisciplinary strategies to reduce radiotherapy-induced cardiotoxicity in breast cancer: surgical and technological innovations
by: Kai Lu, et al.
Published: (2025-08-01)

Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy
by: Yu. A. Vasyuk, et al.
Published: (2021-10-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Natural strategies of preventing anthracycline-induced cardiotoxicity – a review
by: Anca STOICA, et al.
Published: (2022-12-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

Immunomodulatory effects of Lactiplantibacillus plantarum CCFM8661 + stachyose on cyclophosphamide-induced immunosuppression mice
by: Weiwei Ma, et al.
Published: (2025-01-01)

Acrolein exposure associated with kidney damage: a cross‑sectional study
by: Jianchao Ma, et al.
Published: (2025-03-01)

Influence of phloretin on acrolein-induced protein modification and physicochemical changes in a dairy protein model
by: Yanming Zhang, et al.
Published: (2024-12-01)